DeckTherapeutics appoints Dr. Larry Gold to the Board of Directors
DeckTherapeutics today announced that it has appointed Dr. Larry Gold to its Board of Directors.
Dr. Gold is an internationally recognized scientist whose research at the University of Colorado Boulder has spawned numerous discoveries and commercially successful biotechnology patents.
Dr. Gold is the Founder and former Chairman and CEO of SomaLogic. Prior to SomaLogic, he founded and was the Chairman of NeXagen, Inc., later NeXstar Pharmaceuticals, Inc., which merged with Gilead Sciences, Inc. in 1999. In 1981, Dr. Gold co-founded and served as co-director of research at Synergen, Inc. which was later acquired by Amgen, Inc.
Dr. Gold also serves on the board of directors of NASDAQ-listed 180 Life Sciences. He has been a member of the American Academy of Arts and Sciences since 1993 and was elected to the prestigious National Academy of Sciences in 1995.